Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

Gender, CRP, biologic use predict secukinumab effectiveness in patients with PsA
15 Sep 2026
bởiStephen Padilla
Male sex, elevated C-reactive protein (CRP), lower number of previous biologic/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) used, and lower Health Assessment Questionnaire (HAQ) score are all predictive of treatment response in European patients with psoriatic arthritis (PsA) treated with secukinumab, a study has shown.
15 Sep 2026

Aficamten retains upper hand over metoprolol for oHCM in subanalysis
14 Sep 2026
bởiAudrey Abella
Results from a subanalysis of the MAPLE-HCM* trial presented at ESC 2026 continue to support the superiority of aficamten over metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) irrespective of beta-blocker (BB) use at screening and prior standard-of-care (SoC) status.
14 Sep 2026






